← Back to Clinical Trials
Recruiting NCT05849649

NCT05849649 Mobile Application-based Exercise Intervention for Pregnant Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05849649
Status Recruiting
Phase
Sponsor Western Kentucky University
Condition Pregnancy Related
Study Type INTERVENTIONAL
Enrollment 176 participants
Start Date 2023-08-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 44 Years
Study Type INTERVENTIONAL
Interventions
BumptUpEducational Brochure

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 176 participants in total. It began in 2023-08-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overarching goal of this randomized controlled clinical trial is to test the efficacy of the mHealth app (BumptUp) for improving physical activity levels among pregnant and postpartum women in a rural setting. Secondary outcomes include weight status, dietary intake, glucose tolerance, blood pressure, and mental health. Specific Aim 1. Conduct an RCT (N=176) to assess the efficacy of the mHealth intervention for increasing physical activity levels during pregnancy (13-15, 23-25, and 35-37 weeks gestation) and postpartum (6 and 12 weeks) among women in a rural setting. Research Activities: The efficacy of BumptUp® will be determined by measuring physical activity levels (via accelerometry and surveys) between women who use the mobile app (intervention) and women who use only an educational brochure (attention control). Specific Aim 2: Assess the efficacy of the mHealth intervention on important obstetric outcomes including maternal weight status, dietary intake, glucose tolerance, blood pressure, and mental health. Research Activities: Maternal weight status, glucose tolerance, and blood pressure values will be obtained from patient charts. Dietary intake will be assessed via the National Cancer Institute Multifactor Screener. Maternal mental health status will be measured via The Edinberg Postpartum Depression Questionnaire, Center for Epidemiological Studies Depression Scale, and the State-Trait Anxiety Inventory.

Eligibility Criteria

Inclusion Criteria: * Age 18-44 * Confirmed singleton viable pregnancy * English-Speaking (the app is currently only available in English) * Physician release to participate in exercise prior to study participation * Ownership of a smartphone * Patient at either Graves Gilbert Clinic or Women's Health Specialists * Plans to deliver at The Medical Center in Bowling Green, KY. Exclusion Criteria: * Multiple gestation pregnancy * Inability to provide voluntary informed consent * Any medical condition (pregnancy-related or not) that would preclude exercise.

Contact & Investigator

Central Contact

Rachel A Tinius, PhD

✉ rachel.tinius@wku.edu

📞 2707455026

Principal Investigator

Rachel A Tinius, PhD

PRINCIPAL INVESTIGATOR

Western Kentucky University

Frequently Asked Questions

Who can join the NCT05849649 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 44 Years, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05849649 currently recruiting?

Yes, NCT05849649 is actively recruiting participants. Contact the research team at rachel.tinius@wku.edu for enrollment information.

Where is the NCT05849649 trial being conducted?

This trial is being conducted at Bowling Green, United States.

Who is sponsoring the NCT05849649 clinical trial?

NCT05849649 is sponsored by Western Kentucky University. The principal investigator is Rachel A Tinius, PhD at Western Kentucky University. The trial plans to enroll 176 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology